Early analysis suggests monkeypox vaccine is reducing risk of infection in U.S.
A very preliminary analysis of data from 32 states appears to suggest that the monkeypox vaccine being used in the United States is reducing the risk of infection among vaccinated people, Rochelle Walensky, the director of the Centers for Disease Control and Prevention, said Wednesday.
Walensky said the analysis showed that people who were eligible to be vaccinated against monkeypox because of their personal level of risk but who had not received the vaccine were 14 times more likely to contract monkeypox than those who were vaccinated, when the analysis looked at data from two weeks after receipt of a single dose.
